Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib plus S-1 in advanced colorectal cancer
NCT03397199Phase 2Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Jan 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in colorectal cancer (CRC), sponsored by Henan Cancer Hospital. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03397199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03397199.